Axicabtagene ciloleucelCytokine release syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1740卷 / 1期

关键词：

D O I：

10.1007/s40278-019-57947-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：54 / 54

相关论文

共 50 条

[41] Axicabtagene-ciloleucelGrade 2 cytokine release syndrome and grade 1 immune effector cell-associated neurotoxicity syndrome: case report
Reactions Weekly, 2025, 2050 (1) : 91 - 91
[42] Axicabtagene-ciloleucelNeutropenia: case report
Reactions Weekly, 2025, 2045 (1) : 69 - 69
[43] Axicabtagene-ciloleucelColitis: case report
Reactions Weekly, 2022, 1928 (1) : 81 - 81
[44] Axicabtagene ciloleucelHaemophagocytic lymphohistiocytosis: case report
Reactions Weekly, 2022, 1887 (1) : 117 - 117
[45] Axicabtagene-ciloleucel/cyclophosphamide/fludarabineCytokine release syndrome, immune effector cell-associated neurotoxicity syndrome and bone marrow aplasia: case report
Reactions Weekly, 2021, 1876 (1) : 64 - 64
[46] TebentafuspCytokine release syndrome: case report
Reactions Weekly, 2024, 2028 (1) : 479 - 479
[47] TisagenlecleucelCytokine release syndrome: case report
Reactions Weekly, 2020, 1817 (1) : 302 - 302
[48] BlinatumomabCytokine release syndrome: case report
Reactions Weekly, 2016, 1605 (1) : 33 - 33
[49] TisagenlecleucelCytokine release syndrome: case report
Reactions Weekly, 2018, 1684 (1) : 240 - 240
[50] RituximabCytokine release syndrome: case report
Reactions Weekly, 2020, 1830 (1) : 285 - 285

← 1 2 3 4 5 →